美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06667 美因基因

休市中 07-31 16:08:40

7.150

+0.060

+0.85%

最高7.280	最低6.800	成交量5,400
今开6.980	昨收7.090	日振幅6.77%
总市值16.02亿	流通市值16.02亿	总股本2.24亿
成交额3.73万	换手率0.00%	流通股本2.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":7.15,"timestamp":1785485320191,"preClose":7.09,"halted":0,"volume":5400,"delay":0,"changeRate":0.00846262341325818,"floatShares":224000000,"shares":224000000,"eps":0.136851,"marketStatus":"休市中","change":0.06,"latestTime":"07-31 16:08:40","open":6.98,"high":7.28,"low":6.8,"amount":37274,"amplitude":0.067701,"askPrice":7.15,"askSize":4000,"bidPrice":6.8,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.134,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785720600000},"marketStatusCode":7,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":7.09,"dividendRate":0.024283,"openAndCloseTimeList":[[1785461400000,1785470400000],[1785474000000,1785484800000]],"volumeRatio":0.07429829397281044,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667","defaultTab":"news","newsList":[{"id":"1128594791","title":"美因基因回购10.82万股股份，总额约76.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128594791","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128594791?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:56","pubTimestamp":1785232571,"startTime":"0","endTime":"0","summary":"2026年7月28日，美因基因有限公司发布公告称，于香港联合交易所回购股份10.82万股，占该公司于回购前已发行股本约0.0484%，每股回购价格介乎7.08港元至7.10港元，涉资共计约76.61万港元。回购完成后，公司已发行股本从原有的223,640,400股减少至223,532,200股，库藏股从659,800股增至768,000股，合计股份总数保持在224,300,200股。公告显示，本次股份购回依照公司于2026年5月21日通过的购回授权进行，授权可购回股份总数为22,430,020股。公告由董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购10.82万股股份，总额约76.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008503","title":"美因基因(06667.HK)7月28日斥资76.61万港元回购10.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008503","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654008503?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:49","pubTimestamp":1785232159,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158034431","title":"美因基因（06667）宣布更换公司秘书及香港主要营业地点","url":"https://stock-news.laohu8.com/highlight/detail?id=1158034431","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158034431?lang=zh_cn&edition=full","pubTime":"2026-07-27 22:16","pubTimestamp":1785161770,"startTime":"0","endTime":"0","summary":"美因基因有限公司7月27日发布公告称，因个人工作安排，自2026年7月27日起，吴嘉智已辞任公司秘书、香港联合交易所有限公司证券上市规则第3.05条所规定的授权代表，以及公司在香港的法律程序文件代理人。吴嘉智确认与董事会并无任何意见分歧，亦无其他需提请联交所及股东注意的事项。截至公告日，公司董事会成员包括执行董事俞熔、林琳及姜晶；非执行董事郭美玲；独立非执行董事张影、贾庆丰及谢丹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654487045","title":"美因基因(06667)：何伟乐获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2654487045","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654487045?lang=zh_cn&edition=full","pubTime":"2026-07-27 22:11","pubTimestamp":1785161483,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，由于其个人工作安排，吴嘉智先生已辞任(i)公司秘书;(ii)公司根据香港联合交易所有限公司证券上市规则第3.05条所规定之授权代表;及(iii)香港法例第622章公司条例第16部规定于香港代公司接收法律程序文件及通知之授权代表，自2026年7月27日起生效。何伟乐先生获委任为(i)公司秘书;(ii)授权代表;及(iii)法律程序文件代理人，自2026年7月27日起生效。姜晶女士已获指定为公司与何先生联络的主要联络人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113379394","title":"美因基因回购9.12万股股份，总额约66.17万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113379394","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113379394?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:32","pubTimestamp":1785144752,"startTime":"0","endTime":"0","summary":"2026年7月27日，美因基因有限公司公告称，于当日于香港联交所回购股份9.12万股，占回购前公司已发行股本约0.0408%，每股价格介乎7.15港元至7.26港元，总涉资约66.17万港元。回购完成后，公司已发行股本总数维持224,300,200股，其中已发行股份为223,640,400股，库藏股数量增至659,800股。根据公告，股东大会已于2026年5月21日通过回购授权，授权上限为22,430,020股。公司确认相关回购行为已遵守香港联交所证券上市规则及其他适用法规。本公告由公司董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购9.12万股股份，总额约66.17万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654015798","title":"美因基因(06667)7月27日斥资66.17万港元回购9.12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654015798","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654015798?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:28","pubTimestamp":1785144514,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年7月27日，该公司斥资66.17万港元回购9.12万股股份，每股回购价7.15-7.26港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116577984","title":"美因基因：7月24日回购11.00万股，耗资约77.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116577984","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116577984?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:22","pubTimestamp":1784888534,"startTime":"0","endTime":"0","summary":"美因基因有限公司2026年7月24日发布公告，称公司于当日回购了11.00万股普通股，占2026年7月21日既有已发行股本的0.0491%，回购每股价格均为7.08港元，合计付出约77.88万港元。根据公告，购回授权于2026年5月21日经股东大会通过，授权可回购股份的总数为22,430,020股，截至目前累计已回购568,600股，占该授权通过当日已发行股本总数的0.2535%。公司表示，本次交易已获得董事会正式批准，并遵守香港联交所证券上市规则及所有相关法律法规。公告由董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因：7月24日回购11.00万股，耗资约77.88万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653085567","title":"美因基因(06667)7月24日斥资77.88万港元回购11万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653085567","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653085567?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:06","pubTimestamp":1784887603,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年7月24日，该公司斥资77.88万港元回购11万股股份，每股回购价7.08港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164567872","title":"美因基因：7月21日回购108,400股，耗资约77.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164567872","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164567872?lang=zh_cn&edition=full","pubTime":"2026-07-21 17:42","pubTimestamp":1784626957,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年7月21日公告称，公司于当日在香港联合交易所回购公司股份108,400股，占回购前已发行股本的约0.0484%。本次回购价格区间为每股6.98港元至7.15港元，合计耗资775,002港元，折合约77.50万港元。此次股份回购完成后，公司已发行股份数量为223,841,600股，库藏股数量增加至458,600股，合计股份数为224,300,200股。公司于2026年5月21日通过购回授权，授权购回总数为22,430,020股，至今已在交易所累计回购458,600股，占授权通过日已发行股本的约0.2045%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因：7月21日回购108,400股，耗资约77.50万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653273172","title":"美因基因(06667.HK)7月21日斥资77.5万港元回购10.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653273172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653273172?lang=zh_cn&edition=full","pubTime":"2026-07-21 17:41","pubTimestamp":1784626861,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167606484","title":"美因基因回购2,000股股份，总额约1.37万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167606484","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167606484?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:00","pubTimestamp":1784282459,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年7月17日公告，称公司于同日在香港联交所场内回购2,000股普通股，占当日回购前公司已发行股本约0.0009%。本次回购的每股价格为6.85港元，合计耗资约1.37万港元。公告显示，本次回购完成后，公司已发行股份总数减少至223,950,000股，库藏股数量增至350,200股，总股本仍为224,300,200股。根据上市规则要求，公司在回购后30日内将暂时不得发行新股或出售库藏股。公司确认已遵守相关上市规则及适用的法律法规。上述公告由公司董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购2,000股股份，总额约1.37万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652404318","title":"美因基因(06667)7月17日耗资1.37万港元回购2000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652404318","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652404318?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:59","pubTimestamp":1784282361,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)公布，2026年7月17日耗资1.37万港元回购2000股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197439350","title":"美因基因7月14日回购10.02万股股份，耗资约70.53万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197439350","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197439350?lang=zh_cn&edition=full","pubTime":"2026-07-14 17:52","pubTimestamp":1784022772,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年7月14日发布翌日披露报表，公告显示公司当日于香港联交所场内回购普通股100,200股，占回购前已发行股本的约0.0447%。每股回购价在港币6.89港元至7.10港元之间，总耗资约70.53万港元。回购完成后，公司已发行股本由224,052,200股减少至223,952,000股，同时库藏股数量增至348,200股，总已发行股本仍为224,300,200股。美因基因于2026年5月21日获得股东大会通过的回购授权，可回购股份总数为22,430,020股，截至目前累计回购数量为348,200股，占授权时已发行股本的0.1552%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因7月14日回购10.02万股股份，耗资约70.53万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171846","title":"美因基因(06667.HK)7月14日斥资70.53万港元回购10.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651171846?lang=zh_cn&edition=full","pubTime":"2026-07-14 17:47","pubTimestamp":1784022456,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119456978","title":"美因基因回购1万股股份，耗资约6.19万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119456978","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119456978?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:00","pubTimestamp":1783684854,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年7月10日发布公告，披露当日于香港联交所回购公司股份1万股，约占该公司已发行股本的0.0045%，每股回购价介乎6.13港元至6.25港元，总金额约6.19万港元。根据公告，回购授权由股东于2026年5月21日通过，公司最多可回购22,430,020股，迄今已通过香港联交所及其他交易所合计购回股份248,000股。公司同时确认，本次回购行为已遵守香港联交所上市规则及相关法例的规定。公告由董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购1万股股份，耗资约6.19万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650187452","title":"美因基因(06667)7月10日斥资6.19万港元回购1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650187452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650187452?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:00","pubTimestamp":1783684813,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年7月10日斥资6.19万港元回购1万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118880160","title":"美因基因：7月9日回购10.12万股，耗资约74.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118880160","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118880160?lang=zh_cn&edition=full","pubTime":"2026-07-09 18:06","pubTimestamp":1783591561,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年7月9日发布翌日披露报表。公告显示，公司于当日在香港联交所场内回购普通股10.12万股，占回购前公司已发行股本约0.0451%。本次回购的每股价格在6.80港元至7.40港元之间，总耗资约74.10万港元。根据此前于2026年5月21日通过的股份回购授权，公司可回购股份总数为22,430,020股，截至目前累计回购股份238,000股，占上述授权获准当日已发行股本数目约0.1061%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因：7月9日回购10.12万股，耗资约74.10万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649960047","title":"美因基因(06667.HK)7月8日斥资11.74万港元回购1.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649960047","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649960047?lang=zh_cn&edition=full","pubTime":"2026-07-08 18:58","pubTimestamp":1783508301,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164373623","title":"美因基因7月8日回购1.72万股股份，涉资约11.74万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164373623","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164373623?lang=zh_cn&edition=full","pubTime":"2026-07-08 18:58","pubTimestamp":1783508299,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年7月8日发布公告，披露其在港交所场内进行股份回购。本次回购数量为17,200股，占当日公司现有已发行股本约0.0077%。每股回购价介乎港元6.45元至7.00元，合计付出的总金额为117,448港元，折合约11.74万港元。公司此前已于2026年5月21日通过购回授权，授权可回购股份总数为22,430,020股，截至目前公司已根据该授权累计回购136,800股，约占购回授权通过当日已发行股本的0.061%。公司在公告中确认已遵守香港联交所证券上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因7月8日回购1.72万股股份，涉资约11.74万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115601017","title":"美因基因回购9.32万股股份，耗资约69.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115601017","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115601017?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:15","pubTimestamp":1783426546,"startTime":"0","endTime":"0","summary":"7月7日，美因基因有限公司发布公告称，于2026年7月7日通过香港联交所场内回购93,200股普通股，约占其当日已发行股本0.0416%。本次回购的每股价格在港币6.73元至7.43元之间，总耗资约69.12万港元。本次回购完成后，公司已发行股本为224,180,600股，库藏股增至119,600股，总发行股本保持224,300,200股。公司确认已遵守相关上市规则及法律法规要求。公告由董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购9.32万股股份，耗资约69.12万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0056},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.0174},{"period":"ytd","weight":0.0174}],"compareEarnings":[{"period":"1week","weight":0.0369},{"period":"1month","weight":0.1313},{"period":"3month","weight":0.0042},{"period":"6month","weight":-0.0549},{"period":"1year","weight":0.0449},{"period":"ytd","weight":0.0099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断（IVD）管线产品，包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166378},{"month":2,"riseRate":0.75,"avgChangeRate":0.055076},{"month":3,"riseRate":0,"avgChangeRate":-0.048593},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.010548},{"month":5,"riseRate":0.666667,"avgChangeRate":0.005636},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.015012},{"month":7,"riseRate":0.5,"avgChangeRate":0.008854},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.078161},{"month":9,"riseRate":0,"avgChangeRate":-0.165911},{"month":10,"riseRate":0,"avgChangeRate":-0.078395},{"month":11,"riseRate":0.333333,"avgChangeRate":0.114508},{"month":12,"riseRate":0.666667,"avgChangeRate":0.22092}],"exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}